Industry ties to vaccine advocates raises skepticism

Heightened media attention to the financial ties between vaccine makers and the physician groups which advocate their use appears to be encouraging a growing number of parents to skip the jabs for their kids--at a cost. The CDC noted that a recent outbreak of measles, a disease eliminated in the U.S. in 2000, could be attributed to the lack of a vaccination in 63 of 64 cases.

The Wall Street Journal notes that a recent CBS report highlighted millions of dollars in manufacturers' grants to the American Academy of Pediatrics, which is responsible for major immunization campaigns. Drug makers like Merck and Wyeth have contributed hundreds of thousands of dollars to the organizations. The groups insist that they're not swayed by the money, which they say allows them to pursue the work they believe in. But evidently a growing segment of the U.S. population isn't persuaded.

- check out the report in the Wall Street Journal
-
read the CBS story

Suggested Articles

The pandemic price could be lowered for larger deals, CEO Stephane Bancel said. Pfizer and BioNTech priced 100M doses at $19.50 each for the U.S.

Pfizer and BioNTech followed supply pacts in the U.S. and U.K. with a new deal to deliver 120 million vaccines to Japan in the first half of 2021.

Sanofi's cost cuts are adding up, execs said in an update Wednesday. The company has trimmed nearly €1 billion in annual expenses so far in 2020.